Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOICES: Imatinib With or Without Hydroxychloroquine in CML
NCT01227135Phase 2Unknown
- Start
- Mar 2010
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in chronic myeloid leukemia (CML). Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT01227135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01227135.